Restrictive transfusion thresholds reduce blood use in newborns without increasing death risk

Newborns often need platelet transfusions when their blood cell counts drop. But these transfusions carry risks and use precious blood supplies. A new review looked at whether doctors should wait longer before giving these transfusions. The team analyzed data from 856 babies across three studies in different countries. They compared strict rules that wait for lower counts against liberal rules that transfuse earlier. The results show a clear benefit for the babies who needed fewer transfusions. In the group with mild low counts, those under stricter rules received far fewer platelet transfusions. This change happened without causing more deaths or major bleeding events before the babies left the hospital. For babies with severe low counts, the number of transfusions also dropped significantly under the stricter approach. The review found no increase in death or major bleeding for any group when doctors waited longer to transfuse. Even serious outcomes like brain injury or developmental delays showed no difference between the two approaches. However, the evidence has some uncertainty. Only three studies were available, and two were quite small. The designs did not hide who got which treatment, which can influence results. The data was also not precise enough to fully rule out small risks for the most critical outcomes. Despite these limits, the findings suggest that waiting longer to transfuse is a safe choice. This approach helps conserve blood supplies while keeping newborns safe from the extra risks of unnecessary transfusions.